Researchers at Mass General Brigham have identified new biomarkers for tinnitus by measuring pupil dilation and subtle facial movements that correlate with the level of distress caused by the disorder. Published in Science Translational Medicine, the findings could lead to placebo-controlled treatment studies that have largely been not feasible due to lack of objective measures.
“Imagine if cancer severity were determined by giving patients a questionnaire — this is the state of affairs for…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply